Cargando…
Usage of pioglitazone at Medanta, the Medicity
Pioglitazone improves glycemic control by acting as an insulin sensitizer and is used in the management of Type 2 diabetes mellitus. Pioglitazone has recently been at the center of a controversy with regards to its safety. There is no clear consensus on how, when and in what dose the drug should be...
Autores principales: | Mithal, Ambrish, Kaur, Parjeet, Bansal, Beena, Mishra, Sunil Kumar, Wasir, Jasjeet S., Jevalikar, Ganesh, Mahendru, Shama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968715/ https://www.ncbi.nlm.nih.gov/pubmed/24701440 http://dx.doi.org/10.4103/2230-8210.126588 |
Ejemplares similares
-
Medanta insulin protocols in patients undergoing cardiac surgery
por: Bansal, Beena, et al.
Publicado: (2014) -
Long-term efficacy of liraglutide in Indian patients with Type 2 diabetes in a real-world setting
por: Kaur, Parjeet, et al.
Publicado: (2016) -
Adverse Effect Profile and Effectiveness of Sodium Glucose Co-transporter 2 Inhibitors (SGLT2i) - A Prospective Real-world Setting Study
por: Gill, Harmandeep Kaur, et al.
Publicado: (2019) -
Video Consultation Versus In-Person Clinic Visit for Glycemic Control in Type 2 Diabetes during COVID-19 Pandemic (VIP-CD Study)
por: Dutta, Aditya, et al.
Publicado: (2021) -
Lack of association of baseline 25-hydroxyvitamin D levels with disease severity and mortality in Indian patients hospitalized for COVID-19
por: Jevalikar, Ganesh, et al.
Publicado: (2021)